Articles

Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis

Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC
Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC
Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC
Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC
Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC
Centre de recherche en infectiologie du CHUL, Centre de recherche du CHU de Québec – Université Laval, Québec City, QC, Canada; CHU de Québec – Université Laval – Hôpital Enfant-Jésus; Québec City, QC, Canada; Department of Medicine, Université Laval, Quebec City, QC
Centre de recherche en infectiologie du CHUL, Centre de recherche du CHU de Québec – Université Laval, Québec City, QC, Canada; CHU de Québec – Université Laval – Hôpital Enfant-Jésus; Québec City, QC, Canada; Department of Medicine, Université Laval, Quebec City, QC
Division of Hematology-Oncology and Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada; Department of Medicine, Université de Montréal, Montréal, QC
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
Department of pediatrics, division of Hematology, Ste-Justine Hospital, Montréal, QC
Centre de recherche en infectiologie du CHUL, Centre de recherche du CHU de Québec – Université Laval, Québec City, QC, Canada; CHU de Québec – Université Laval – Hôpital Enfant-Jésus; Québec City, QC, Canada; Department of Medicine, Université Laval, Quebec City, QC
Laboratory for High Throughput Biology, Institute for Research in Immunology and Cancer, Montréal, QC, Canada; Department of Medicine, Université de Montréal, Montréal, QC
Haematologica Early view Dec 30, 2020 https://doi.org/10.3324/haematol.2020.271619